Huntington National Bank’s Lifecore Biomedical LFCR Stock Holding History

Huntington National Bank’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4	Hold	1	–	–	﹤0.01%	3952
2025 Q4	$8	Hold	1	–	–	﹤0.01%	3731
2025 Q3	$7	Hold	1	–	–	﹤0.01%	3793
2025 Q2	$8	Hold	1	–	–	﹤0.01%	3762
2025 Q1	$7	Hold	1	–	–	﹤0.01%	3810
2024 Q4	$7	Hold	1	–	–	﹤0.01%	3817
2024 Q3	$5	Hold	1	–	–	﹤0.01%	3885
2024 Q2	$5	Hold	1	–	–	﹤0.01%	3830
2024 Q1	$5	Hold	1	–	–	﹤0.01%	3700
2023 Q4	$6	Hold	1	–	–	﹤0.01%	3570
2023 Q3	$8	Hold	1	–	–	﹤0.01%	3481
2023 Q2	$10	Hold	1	–	–	﹤0.01%	3391
2023 Q1	$4	Hold	1	–	–	﹤0.01%	3430
2022 Q4	$6	Hold	1	–	–	﹤0.01%	3225
2022 Q3	$0	Hold	1	–	–	﹤0.01%	2220
2022 Q2	$0	Hold	1	–	–	﹤0.01%	2239
2022 Q1	$0	Hold	1	–	–	﹤0.01%	2206
2021 Q4	$0	Hold	1	–	–	﹤0.01%	2161
2021 Q3	$0	Hold	1	–	–	﹤0.01%	1907
2021 Q2	$0	Hold	1	–	–	﹤0.01%	1824
2021 Q1	$0	Hold	1	–	–	﹤0.01%	1714
2020 Q4	$0	Hold	1	–	–	﹤0.01%	1673
2020 Q3	$0	Hold	1	–	–	﹤0.01%	1636
2020 Q2	$0	Hold	1	–	–	﹤0.01%	1628
2020 Q1	$0	Hold	1	–	–	﹤0.01%	1689
2019 Q4	$0	Hold	1	–	–	﹤0.01%	1775
2019 Q3	$0	Hold	1	–	–	﹤0.01%	1646
2019 Q2	$0	Buy	+1	New	+$10	﹤0.01%	1696

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Huntington National Bank's LFCR Position: Q1 2026 in Review

Huntington National Bank held its Lifecore Biomedical (LFCR) position steady in Q1 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #3952.

Huntington National Bank first reported a position in LFCR in Q2 2019 and has held it in 28 quarters since. The position peaked at $10 in Q2 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

Huntington National Bank held 1 share of Lifecore Biomedical worth $4 as of Q1 2026.
Huntington National Bank left its Lifecore Biomedical share count unchanged in Q1 2026.
Lifecore Biomedical made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3952 holding.
Huntington National Bank first reported a position in Lifecore Biomedical in Q2 2019 and has held it in 28 quarters since.
Huntington National Bank's Lifecore Biomedical position peaked at $10 in Q2 2023.
105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.